Newsletter

Navigating the Challenges of COVID-19 Vaccination: Updates and Concerns

Worried, there is no COVID vaccine to administer.

Go back in timeCOVID-19 pandemic situation It can be said that everything in the world is in a state of stagnation. The impact is broad, not only in the health dimension. including other aspects of the economy and society

This is because at that moment COVID19 is a new emerging disease. who still have no knowledge about the disease, including prevention, symptoms and severity of the disease AND there is no vaccine for protection. Before that, we started to have more knowledge about this disease, especially about contact prevention.

Vaccine against covid Therefore, the world’s hope is to stop the spread of COVID-19. prompting many companies to accelerate vaccine research and development Before gradually releasing the results of each company’s COVID vaccine trials.
Many countries including Thailand COVID vaccine registration is starting, butEmergency Use Authorization (EUA) by regulators in each country Consider the results of testing the vaccine in humans (it may or may not have already been studied in Phase 3) so that it can be used with the target population in that country.

Dr. Narong Aphikulwanich, secretary general of the Food and Drug Administration, said that during the outbreak of the diseaseCOVID-19 There is not yet a vaccine to prevent the spread and reduce the severity of the disease. But for people to have the vaccine to use quickly and in a timely manner

The FDA therefore requires conditional registration of drugs in emergency situations (EUA) where there is an urgent need. It establishes guidelines for companies wishing to register to provide sufficient information to support the quality, effectiveness and safety of vaccines. Including having to closely monitor security.

“Despite the shorter evaluation time, the FDA continues to focus on evidence indicating the safety, quality and effectiveness of the vaccines,” Dr. Narong said.

People’s concerns about the COVID vaccine at the time were: “No vaccine, no vaccination. and have not received the desired vaccine,” although there may be some concerns about the effects of the COVID vaccine, which is considered a new type of vaccine. But the fear of Covid is greater. Until there was a deterioration of the inactivated vaccine that the government procured and asked the state to procure.RNA vaccines desired

Entering the era of fear over the effects of COVID vaccination.

Time has passed. Knowledge of the disease severity of the disease and further treatment guidelines In addition, many people in Thailand have received the COVID vaccine. The epidemic situation is gradually easing and in ThailandAnnouncement of the cancellation of the disease COVID-19 as a dangerous contagious disease
Currently, the number of people admittedAnti-Covid vaccination In Thailand, only the mRNA COVID vaccine is available. Pfizer vaccine ANDModern vaccine and there were no further procurements. But almost no one received the shot.

A new concern has emerged, going from “fear of not having the injection” to “already having the anti-Covid vaccine”. It will have a long-term effect on the body.

Especially the side effects that may occur. This has been specified since registration for emergency use, such as the risk of myocarditis and pericarditis. of the Pfizer anti-COVID vaccine Thrombosis caused by the AstraZeneca vaccine

Pfizer vaccine lawsuit

He collaborates abroad, especially in America and Europe. In particular, lawsuits against vaccine manufacturers are starting to appearPfizer vaccine which are widely used in that area, as in the case of the Hamburg Regional Court Germany has begun to consider a lawsuit against BioNTech and Pfizer, a giant US pharmaceutical company.mRNA vaccine The first is Comirnaty.

This comes from a lawsuit filed by a woman who claims the COVID vaccine caused her dangerous side effects.
Including the case of Texas Attorney General Ken Faxton. Litigation initiated over allegations of Gain of Function (GOF) research by Pfizer
Furthermore, Thai academics have come out to identify the case of finding a foreign object resembling a white blood clot (White clot) in the blood vessels of a deceased person who received COVID-19 vaccination.

In this case, the National Vaccine Institute released a statement saying that the foreign matter referred to is NOT a blood disease caused by mRNA vaccination at all, it is just a deposit of proteins that make up the blood that occurs after death. (post-mortem blood clot) which is a natural phenomenon normally found in deceased people. and has been seen since before the outbreak or use of the COVID-19 vaccine.

AstraZeneca Thrombosis Vaccine

Latest news published Referring to a class action lawsuit in the UK. Information about side effects after receiving the COVID vaccine from the AstraZeneca company found blood clots leading to death, while the Astra Company disputed such claims. But he admitted it for the first time in a court document. In some cases, vaccines can cause TTS, or thrombotic thrombocytopenia.

It can happen even without the Astra vaccine. or any vaccine The cause in any case will be a matter of expert evidence.
The National Vaccine Institute case released a statement saying that This information is not new. But this is information obtained from systematic data collection. Since the beginning of widespread use of the AstraZeneca COVID-19 virus vector vaccine, data from around the world have found that TTS occurs after receiving the COVID-19 virus vector vaccine. It is a very rare adverse event.

According to data from the United Kingdom (as of 14 June 2021) and the European Union, the risk of TTS for the regional population is predicted to be 1 case per 100,000 people, while the AstraZeneca Global Safety Database found that the rate of reported TTS per 1,000,000 people ranges from 0.2 (in Asian countries and Brazil) to 17.6 (in Nordic countries).

for Thailand A total of 48,730,984 doses of the AstraZeneca COVID-19 vaccine have been administered. Seven cases of suspected or confirmed thrombosis with low platelets were found. The incidence of TTS is 0.014 per 100,000 population or this condition will be found in 10,000,000 people who have received the vaccine.

and TTS occurring after vaccination This most often occurs within the first 3 to 21 days after receiving the vaccine.

While Dr. Thongchai Keeratihatthayakorn Director General of the Department of Disease Control said that a total of 48 million doses of the Astra vaccine have been administered in Thailand, of which one person has received two doses, so there are about 20 million vaccine recipients. There were 23 reports of people developing blood clots after receiving the Astra vaccine, but the subcommittee that considers adverse events in the principles of administering the COVID-19 vaccine considered and found that there were 7 patients with blood clots that may have been caused by the vaccine, of which 2. died.

Update on the Covid vaccine, Thai national

Dr. Nakhon Premsri, Director of the National Vaccine Institute Mentioning the development of the Thai COVID vaccine Not continued at Chulalongkorn University Because it would not have been possible to do research studies at that time. But with the breed constantly changing, however, knowledge was gained during development considered beneficial to the country

Government pharmaceutical organization that researches, develops and produces COVID vaccines Having previously received conditional registration approval from the Food and Drug Administration (FDA), it is still necessary to develop the breed on time and in line with the situation.

“Knowledge and potential deriving from the research and development of anti-COVID vaccines. It can be used in the future If there is another epidemic Many countries are also It is a cost of developing each country’s potential,” Dr. Nakhon said.

Anti-Covid vaccination in the next phase

ForAnti-Covid vaccinationof Thailand in the COVID19 situation It is currently not a dangerous contagious disease and the vaccine is no longer used in emergencies. The use of the vaccine must be in the form of a vaccine under normal conditions. It must be a vaccine that has undergone a process of studying the benefits, disadvantages and various effects and which has been requested to be authorized for registration with the FDA. WhichThere is currently only one vaccine registered for normal use in Thailand, and that is the Pfizer vaccine, which is an mRNA vaccine.

As for providing vaccination services to the public, it is not free for all. If it is administered to the target group that needs it like the flu vaccine, It must be specified as a benefit package in the state health insurance.

In this regard, include the vaccine in the benefits package. It must be considered by the Immunization Subcommittee. chaired by the director general of the Department of Disease Control Before joining the Subcommittee for the Development of the National List of Primary Vaccines, with Assoc. Prof. (Special) Dr. Thawee Choti Pittayasunon is the chairperson to be included in the National List of Essential Medicines. Then you can proceed with entering the benefits package.

However, the Department of Disease Control of the Ministry of Public Health posted on Facebook saying it was asking for the public’s cooperation in answering the questionnaire. “Reception opinionVaccine against covid-19 in the year 2024” from now until May 15, 2024. The information obtained will be used to consider the COVID19 vaccine management policy in the next phase.

#AntiCovid #vaccine #day #today #Fear #inject #concerns #arise